Sökning: onr:"swepub:oai:lup.lub.lu.se:88935f5f-2d4d-4f16-bd62-42217f8dd08f" > Novel Selective Gal...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03937naa a2200433 4500 | |
001 | oai:lup.lub.lu.se:88935f5f-2d4d-4f16-bd62-42217f8dd08f | |
003 | SwePub | |
008 | 220902s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/88935f5f-2d4d-4f16-bd62-42217f8dd08f2 URI |
024 | 7 | a https://doi.org/10.1021/acs.jmedchem.1c012962 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Bum-Erdene, Khuchtumuru Griffith University4 aut |
245 | 1 0 | a Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia |
264 | c 2022-04-15 | |
264 | 1 | b American Chemical Society (ACS),c 2022 |
300 | a 15 s. | |
520 | a Galectin-3 is a β-galactoside-specific, carbohydrate-recognizing protein (lectin) that is strongly implicated in cancer development, metastasis, and drug resistance. Galectin-3 promotes migration and ability to withstand drug treatment of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells. Due to high amino acid conservation among galectins and the shallow nature of their glycan-binding site, the design of selective potent antagonists targeting galectin-3 is challenging. Herein, we report the design and synthesis of novel taloside-based antagonists of galectin-3 with enhanced affinity and selectivity. The molecules were optimized by in silico docking, selectivity was established against four galectins, and the binding modes were confirmed by elucidation of X-ray crystal structures. Critically, the specific inhibition of galectin-3-induced BCP-ALL cell agglutination was demonstrated. The compounds decreased the viability of ALL cells even when grown in the presence of protective stromal cells. We conclude that these compounds are promising leads for therapeutics, targeting the tumor-supportive activities of galectin-3 in cancer. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Läkemedelskemi0 (SwePub)301032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medicinal Chemistry0 (SwePub)301032 hsv//eng |
700 | 1 | a Collins, Patrick M.u Griffith University4 aut |
700 | 1 | a Hugo, Matthew W.u Griffith University4 aut |
700 | 1 | a Tarighat, Somayeh S.u Children's Hospital Los Angeles4 aut |
700 | 1 | a Fei, Feiu Children's Hospital Los Angeles4 aut |
700 | 1 | a Kishor, Chandanu Griffith University4 aut |
700 | 1 | a Leffler, Hakonu Lund University,Lunds universitet,Avdelningen för mikrobiologi, immunologi och glykobiologi - MIG,Institutionen för laboratoriemedicin,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Division of Microbiology, Immunology and Glycobiology - MIG,Department of Laboratory Medicine,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments4 aut0 (Swepub:lu)mmb-hle |
700 | 1 | a Nilsson, Ulf J.u Lund University,Lunds universitet,Centrum för analys och syntes,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Centre for Analysis and Synthesis,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH4 aut0 (Swepub:lu)ok2-uni |
700 | 1 | a Groffen, Johnu Children's Hospital Los Angeles4 aut |
700 | 1 | a Grice, I. Darrenu Griffith University4 aut |
700 | 1 | a Heisterkamp, Norau Children's Hospital Los Angeles4 aut |
700 | 1 | a Blanchard, Helenu Griffith University4 aut |
710 | 2 | a Griffith Universityb Children's Hospital Los Angeles4 org |
773 | 0 | t Journal of Medicinal Chemistryd : American Chemical Society (ACS)g 65:8, s. 5975-5989q 65:8<5975-5989x 0022-2623x 1520-4804 |
856 | 4 | u http://dx.doi.org/10.1021/acs.jmedchem.1c01296y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/88935f5f-2d4d-4f16-bd62-42217f8dd08f |
856 | 4 8 | u https://doi.org/10.1021/acs.jmedchem.1c01296 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.